v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues $ 351,768 $ 344,334 $ 688,363 $ 673,642
Cost of goods sold 271,724 276,188 532,010 541,147
Gross profit 80,044 68,146 156,353 132,495
Selling, general, and administrative expenses 59,400 55,566 118,034 106,910
Operating income 20,644 12,580 38,319 25,585
Other expenses (income):        
Interest expense 154 172 308 342
Other expense (income), net (9,302) (179) (10,074) (450)
Total other expenses (income) (9,148) (7) (9,766) (108)
Income before income taxes 29,792 12,587 48,085 25,693
Provision for income taxes 7,671 3,760 12,420 7,593
Net income 22,121 8,827 35,665 18,100
Less net income (loss) attributable to non-controlling interests 249 (203) 498 (378)
Net income attributable to Guardian Pharmacy Services, Inc. $ 21,872 $ 9,030 $ 35,167 $ 18,478
Class A and Class B common stock [Member]        
Net income per share of Class A and Class B common stock        
Basic [1] $ 0.35 $ 0.15 $ 0.56 $ 0.3
Diluted [1] $ 0.34 $ 0.14 $ 0.55 $ 0.29
Weighted-average Class A and Class B common shares outstanding        
Basic 63,327 62,046 63,324 62,045
Diluted 63,836 63,203 63,757 63,055
[1] See Note 6 - Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share.